Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Margaret Turner Warwick Chair of Thoracic Medicine







Guy Scadding BuildingRoyal Brompton Campus





Gisli Jenkins is a respiratory physician and cell & molecular biologist studying how the lung responds to injury to understand what drives progressive pulmonary fibrosis rather healing, repair and regeneration. He is an NIHR Research Professor, he leads the Margaret Turner Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute and is an honorary consultant physician at the Royal Brompton Hospital, London.



Leavy OC, Kawano-Dourado L, Stewart ID, et al., 2024, Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study., Thorax

Calver J, Parmar N, Harris G, et al., 2024, Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosis., Journal of Biological Chemistry, ISSN:0021-9258

Kawano-Dourado L, Kulkarni T, Ryerson CJ, et al., 2024, Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases, Thorax, ISSN:0040-6376, Pages:1-8

Barth S, Edwards C, Borton R, et al., 2024, REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease., Bmj Open Respir Res, Vol:11

Francesco L, Stewart I, Fabbri L, et al., 2024, Mycophenolate and Azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis, Bmj Open Respiratory Research, Vol:11, ISSN:2052-4439

More Publications